Standard response letters (SRLs) are a tool frequently used by Medical Affairs departments to answer common questions received about the products they support. A well-written SRL not only helps to…
Med Communications, Inc. celebrated the official opening of its new North American headquarters in Clark Tower on Monday, October 18, during an open house and ribbon-cutting ceremony. “At our previous…
With the world of life sciences changing almost daily, navigating information overload in the pharmacovigilance space and keeping abreast of all relevant regulatory information has become critical — and increasingly…
At Med Communications, we have a large population of female pharmacists, so please join us in celebrating Women Pharmacist Day. Created four years ago by Suzanne Soliman of the Pharmacist…
Are you looking for a company with a Med Affairs staff that has a high level of experience in a remote model? Med Communications knows what it takes to be…
Med Communications seamlessly provides omnichannel, high-level clinician contact for healthcare providers and consumers. Our clinical staff have advanced degrees and are available to communicate fair and balanced medical information via…
“The scientific content written by the Med Communications team was good right out of the box, needing minimal revision, which decreased the amount of time from the beginning of the…
August is National Immunization Awareness Month. Now more than ever, it’s important for health care professionals to protect patients of all ages against vaccine-preventable diseases through on-time vaccination. Med Communications…
Patient safety is the ultimate objective of any pharmacovigilance (PV) or drug safety department. The appropriate number of qualified, trained personnel are needed to ensure quality pharmacovigilance processes and outcomes…
What Is a Pharmacovigilance SOP? Pharmacovigilance SOPs, or standard operating procedures, are written instructions that outline the processes and steps involved in monitoring the effects of drugs, helping ensure the…
